Evidence map›Paper›PMID 29681780›Full record

ArticleContrast media & molecular imaging2018

Clinical and Prognostic Value of PET/CT Imaging with Combination of

Panpan Zhang, Jiangyuan Yu, Jie Li, Lin Shen, Nan Li, Hua Zhu, Shizhen Zhai, Yan Zhang, Zhi Yang, Ming Lu

Open access · hybridAbstract read
In one paragraph

Article in Contrast media & molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Comparison of PET/CT usingEuropean journal of nuclear medicine and molecular imaging · 2025
    Observational
  6. The clinical benefits of [BMC medical imaging · 2025
    Article
  7. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Integrating Theranostics Into Patient Care Pathways:AJR. American journal of roentgenology · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Panpan ZhangDepartment of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Jiangyuan YuDepartment of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Jie LiDepartment of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Lin ShenDepartment of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.ORCID 0000-0002-8798-4756
Nan LiDepartment of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Hua ZhuDepartment of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Shizhen ZhaiDepartment of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Yan ZhangDepartment of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Zhi YangDepartment of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.ORCID 0000-0003-2084-5193
Ming LuDepartment of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.ORCID 0000-0002-0647-9361
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To evaluate the clinical and prognostic value of PET/CT with combination of Method: 83 patients of GEP-NENs who underwent Result: For groups A/B/C, the sensitivities of Conclusions: The sensitivity of dual tracers was correlated with cell differentiation, and a correlation between Ki-67 and both SUV

Indexed as

AdultAgedBone NeoplasmsFemaleFluorodeoxyglucose F18Gallium RadioisotopesHumansIntestinal NeoplasmsKi-67 AntigenLymph NodesMaleMiddle AgedMultimodal ImagingNeoplasm MetastasisNeuroendocrine TumorsOrganometallic CompoundsFluorodeoxyglucose F18gallium Ga 68 dotatateGallium RadioisotopesKi-67 AntigenOrganometallic CompoundsRadiopharmaceuticals

Identifiers

PMID29681780
PMCPMC5846381
OpenAlexW2789282818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.